EP 0879449 A2 19981125 - METHOD FOR SELECTING MEDICAL AND BIOCHEMICAL DIAGNOSTIC TESTS USING NEURAL NETWORK-RELATED APPLICATIONS
Title (en)
METHOD FOR SELECTING MEDICAL AND BIOCHEMICAL DIAGNOSTIC TESTS USING NEURAL NETWORK-RELATED APPLICATIONS
Title (de)
VERFAHREN ZUM AUSWÄHLEN VON MEDIZINISCHEM UND BIOCHEMISCHEM DIAGNOSTISCHEN TEST UNTER VERWENDUNG VON AUF NEURALEN NETWERKEN BASIERENDEN ANWENDUNGEN
Title (fr)
METHODE POUR SELECTIONNER DES EXAMENS DIAGNOSTIQUES MEDICAUX ET BIOCHIMIQUES A L'AIDE D'APPLICATIONS APPARENTEES AUX RESEAUX NEURONAUX
Publication
Application
Priority
- US 9702104 W 19970207
- US 59927596 A 19960209
- US 1144996 P 19960209
Abstract (en)
[origin: WO9729447A2] Methods are provided for developing medical diagnostic tests using decision-support systems, such as neural networks. Patient data or information, typically patient history or clinical data, are analyzed by the decision-support systems to identify important or relevant variables and decision-support systems are trained on the patient data. Patient data are augmented by biochemical test data, or results, where available, to refine performance. The resulting decision-support systems are employed to evaluate specific observation values and test results, to guide the development of biochemical or other diagnostic tests, to assess a course of treatment, to identify new diagnostic tests and disease markers, to identify useful therapies, and to provide the decision-support functionality for the test. Methods for identification of important input variables for medical diagnostic tests for use in training the decision-support systems to guide the development of the tests, for improving the sensitivity and specificity of such tests, and for selecting diagnostic tests that improve overall diagnosis of, or potential for, a disease state and that permit the effectiveness of a selected therapeutic protocol to be assessed are provided. The methods for identification can be applied in any field in which statistics are used to determine outcomes. A method for evaluating the effectiveness of any given diagnostic test is also provided.
IPC 1-7
IPC 8 full level
A61B 10/00 (2006.01); A61B 5/00 (2006.01); G01N 33/48 (2006.01); G06F 15/18 (2006.01); G06F 19/00 (2011.01); G06N 3/00 (2006.01); G06N 3/02 (2006.01); G06N 3/04 (2006.01); G06N 3/08 (2006.01); G06N 5/04 (2006.01); G06Q 50/00 (2006.01)
CPC (source: EP)
G16H 15/00 (2017.12); G16H 10/20 (2017.12); G16H 10/60 (2017.12); G16H 50/20 (2017.12); G16H 50/70 (2017.12)
Citation (search report)
See references of WO 9729447A2
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE
DOCDB simple family (publication)
WO 9729447 A2 19970814; WO 9729447 A3 19980507; AU 2316297 A 19970828; CA 2244913 A1 19970814; EP 0879449 A2 19981125; JP 2000501869 A 20000215; JP 2004041713 A 20040212; JP 2005319301 A 20051117; JP 2006172461 A 20060629; JP 2008065836 A 20080321; JP 2008136874 A 20080619; JP 3480940 B2 20031222; JP 3782792 B2 20060607; JP 4139822 B2 20080827; JP 4168187 B2 20081022
DOCDB simple family (application)
US 9702104 W 19970207; AU 2316297 A 19970207; CA 2244913 A 19970207; EP 97915835 A 19970207; JP 2003141050 A 20030519; JP 2005134396 A 20050502; JP 2005357564 A 20051212; JP 2007235531 A 20070911; JP 2008000723 A 20080107; JP 52872997 A 19970207